HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 204 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,052,933 | -81.6% | 34,900 | -79.5% | 0.64% | -81.5% |
| Q1 2024 | $5,708,600 | +21.9% | 170,000 | +17.2% | 3.47% | -5.3% |
| Q4 2023 | $4,683,500 | +26.3% | 145,000 | +90.8% | 3.67% | -57.1% |
| Q2 2022 | $3,707,000 | -36.5% | 76,000 | -36.7% | 8.54% | -8.1% |
| Q1 2022 | $5,838,000 | -29.8% | 120,000 | -38.5% | 9.30% | -20.7% |
| Q4 2021 | $8,315,000 | +17.3% | 195,000 | +5.4% | 11.72% | +10.3% |
| Q3 2021 | $7,091,000 | – | 185,000 | – | 10.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $545,757,000 | 83.25% |
| Nan Fung Group Holdings Ltd | 768,708 | $37,398,000 | 17.74% |
| venBio Partners LLC | 1,544,484 | $75,139,000 | 16.66% |
| Vivo Capital, LLC | 4,570,148 | $222,338,000 | 15.31% |
| HealthInvest Partners AB | 120,000 | $5,838,000 | 9.30% |
| Aisling Capital Management LP | 342,815 | $16,678,000 | 9.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 205,474 | $20,533,000 | 4.63% |
| ASHFORD CAPITAL MANAGEMENT INC | 659,873 | $32,103,000 | 3.46% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $14,595,000 | 2.92% |
| Newlight Partners LP | 651,372 | $31,689,000 | 2.15% |